People who have the life threatening disease of lungs in which there is continuous high BP in the arteries of the lungs, can now have a new medication option.
The FDA (Food and Drug Administration) they had approved Letairis for the treatment of pulmonary arterial hypertension. In this case there is always high BP in the arteries that carry poor oxygenated blood from the heart to the lungs of humans. When arteries narrow down, the heart is required to pump hard, as a result it become weak with the passage of time. This disease affects nearly100, 000 persons in the U.S.
The medicine, named as ambrisentan, is manufactured by Gilead Sciences Inc. it is based in Foster City, Calif. The manufacturer mentions that the medicine would be available in the market from next week. The pill will cost $3,940 per month.
Yoga
Pictures of 200 Calories of Various Foods
VideoGame Therapy for Kids with ADHD
No comments:
Post a Comment